About this trial
Hypothesis: Nosten® device is able to reduce the time of underinflated balloon and removes excess pressure. This device may thus reduce the risk of ventilator-acquired pneumonia (VAP) and early tracheal lesions resulting from intubation with decreased discomfort, morbidity, and nursing workload.
The main objective of the investigators is to show that Nosten® device is more effective than monitoring and manual inflation of the balloon of the tracheal tube to prevent VAP occurrence.
Eligibility criteria
Qualifiers
Patients aged ≥18 years
Patients admitted in the ICU, mechanically ventilated and whose trachea was intubated by the oral route using tubes with catheter polyvinyl chloride "high-volume low pressure" and of standard shape tubes Intubation indication is decided by the physicians in charge according to the usual criteria of respiratory, neurological and /or hemodynamic failure
With an expected duration of mechanical ventilation > 48 hours
Disqualifiers
Patients intubated by nasotracheal route
Patients with tracheotomy before admission
Patients intubated with a polyurethane balloon catheter or a polyvinyl chloride balloon catheter of conical shape
Previously intubated patients for > 48 hours before their possible recruitment
Trial design
Treatments tested in this trial
- Nosten® pressure control (it's not an antibiotic, but simple device)
- Manual pressure control